Udupi/New Delhi, Jul 5 (PTI) Tejas was diagnosed with autism spectrum disorder (ASD) at the age of three, after his parents noticed delayed speech, poor eye contact and limited social interaction. The ...

Investors are betting that a deeper understanding of the brain will allow BCI systems to address the significant unmet need affecting millions of people with neurological disorders. They are also ...

Our immune system works around the clock to protect us from bacteria, viruses, and other harmful germs. It also helps repair damaged tissues after injuries. One of its most important defense tools is ...

The firm submitted applications based on data from the Phase III NIMBLE trial, in which cemdisiran improved patients' ability to do daily tasks.

Greetings, and welcome to the Nuvectis Pharma Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. It's now my pleasure to turn the call over to Ron Bentsur, ...

RNA editing, personalized mRNA, and 'extrahepatic delivery' become the next axes of competition... RNA editing technology emerges as a leading candidate for 'next-generation nucleic acid medicine' In ...

Welcome to Regeneron's conference call to discuss its C5 Complement Development Program. My name is Shannon, and I will be your operator for today's call. [Operator Instructions] Please note that this ...

RTW Investments established a new position in Apellis Pharmaceuticals, adding 7,666,764 shares during the fourth quarter. The quarter-end value of the Apellis stake was $192.59 million, reflecting the ...

DeepRare, an agentic AI system integrating 40 specialised tools, outperformed medical specialists in identifying rare conditions in a head-to-head study published in Nature. For millions of people ...

Quantum computers—devices that process information using quantum mechanical effects—have long been expected to outperform classical systems on certain tasks. Over the past few decades, researchers ...

Please provide your email address to receive an email when new articles are posted on . Pegcetacoplan reduced proteinuria in patients with rare complement-mediated glomerular diseases vs. placebo.

A sudden sensation of numbness? The nagging headache that just won’t quit? That weird weakness in your leg? They’re all symptoms of neurological disorders — a family of conditions that affects more ...